Life Sciences

Schoenherr, Dorda, and BPV Huegel Advise on Raiffeisen-Holding NO-Wien’s EUR 100 Million Investment in Mavie Next and Mavie Holding

Schoenherr has advised healthcare provider Mavie Next and its shareholder Mavie Holding, both part of the UNIQA Group, on Raiffeisen-Holding Niederosterreich-Wien’s planned investment of around EUR 100 million in Mavie Next. Dorda and BPV Huegel advised Raiffeisen-Holding NO-Wien. Heuking Kuehn Lueer Wojtek and Wardynski & Partners reportedly advised Raiffeisen-Holding NO-Wien as well.

SSW and MKS Partners Advise on United Clinics' Acquisition of Two Dental Clinics

SSW has advised United Clinics on its acquisition of Tarabula and Bellodent dental clinics. MKS Partners advised the family foundations that sold the clinics.

Schoenherr Advises mBank on Financing for NU-MED

Schoenherr has advised mBank on a financing package for NU-MED.

Walless Advises Vugene on EUR 1 Million Funding Round to Scale Multi-Omics Platform

Walless has advised Lithuanian biotech startup Vugene on its EUR 1 million investment round led by Superhero Capital, with participation from NGL Ventures, Coinvest Capital, and a syndicate of angel investors. TGS Baltic reportedly advised Superhero Capital and Coinvest Capital.

Schoenherr Advises RetInSight on Sale to Topcon Healthcare

Schoenherr has advised AI ophthalmology spin-off RetInSight and its founding shareholders on the sale to Topcon Healthcare. Dorda reportedly advised Topcon Healthcare.

Schoenherr Advises Enterprise Investors on Acquisition of CM Internus

Schoenherr has advised Enterprise Investors on the acquisition of a 100% stake in Centrum Medyczne Internus. DLA Piper reportedly advised the sellers.